(E)-4-CHLORO-2-(3-(4-PENTYLPHENYL)ACRYLAMIDO)BENZOIC ACID, 95.0%, 1g

2,3-Dichloro-5,6-dicyano-1,4-benzoquinone, 96.0%, 100g

3,3-Dimethylpiperidin-4-ol hydrochloride, 1g

3-Chloro-2,6-difluoroaniline, 95.0%, 10g

BOC-2-PROPARGYL-L-GLYCINOL, 97.0%, 5g

Sodium 2-Acrylamido-2-methylpropane-1-sulfonate (ca. 50% in Water) (stabilized with MEHQ)100g

2,2-Dimethyl-1,3-dioxolane>98.0%(GC)25mL

1-Iodo-4-(trans-4-pentylcyclohexyl)benzene, 95.0%, 5g

9-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one, 97%, 250mg

N-éthyl-2-pyrrolidone, min 98 %, pour la synthèse, 25 l, avec bl.

6-Methyl-2-(2-trifluoromethylbenzoyl)pyridine, 97.0%, 1g

2-Methoxypyrimidine-5-carbonitrile, 97%, 250mg

trans-2-Phenyl-1-cyclopropanecarboxylic Acid>98.0%(T)5g